Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo

DNA and Cell Biology

Volumn 30, Issue 10, 2011, Pages 751-761

  Multhaup, Megan M ^a   Gurram, Sweta ^a   Podetz Pedersen, Kelly M ^a   Karlen, Andrea D ^a   Swanson, Debra L ^a   Somia, Nikunj V ^a   Hackett, Perry B ^a   Cowan, Morton J ^b   McIvor, R Scott ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; EX VIVO GENE TRANSFER; GENE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION INITIATION SITE;

5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL LINE; DNA REPAIR; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; NUCLEAR PROTEINS; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEVERE COMBINED IMMUNODEFICIENCY; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 80053523133     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1244     Document Type: Article

References (29)

1. Agarwal, S., Nikolai, B., Yamaguchi, T., Lech, P., and Somia, N.V. (2006). Construction and use of retroviral vectors encoding the toxic gene barnase. Mol Ther 14, 555-563. (Pubitemid 44296091)
2. Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, R.H., Bregni, M., Marktel, S., Valsecchi, M.G., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., and Roncarolo, M.G. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360, 447-458.
3. Amorosi, S., Russo, I., Amodio, G., Garbi, C., Vitiello, L., Palamaro, L., Adriani, M., Vigliano, I., and Pignata, C. (2009). The cellular amount of the common gamma-chain influences spontaneous or induced cell proliferation. J Immunol 182, 3304-3309.
4. Benjelloun, F., Garrigue, A., Demerens-de Chappedelaine, C., Soulas-Sprauel, P., Malassis-Seris, M., Stockholm, D., Hauer, J., Blondeau, J., Riviere, J., Lim, A., Le Lorc'h, M., Romana, S., Brousse, N., Paques, F., Galy, A., Charneau, P., Fischer, A., de Villartay, J.P., and Cavazzana-Calvo, M. (2008). Stable and functional lymphoid reconstitution in Artemis-deficient mice following lentiviral Artemis gene transfer into hematopoietic stem cells. Mol Ther 16, 1490-1499.
5. Britton, S., Frit, P., Biard, D., Salles, B., and Calsou, P. (2009). ARTEMIS nuclease facilitates apoptotic chromatin cleavage. Cancer Res 69, 8120-8126.
6. Connelly, M.A., Zhang, H., Kieleczawa, J., and Anderson, C.W. (1998). The promoters for human DNA-PKcs (PRKDC) and MCM4: divergently transcribed genes located at chromosome 8 band q11. Genomics 47, 71-83. (Pubitemid 28080083)
7. Gaspar, H.B., Parsley, K.L., Howe, S., King, D., Gilmour, K.C., Sinclair, J., Brouns, G., Schmidt, M., Von Kalle, C., Barington, T., Jakobsen, M.A., Christensen, H.O., Al Ghonaium, A., White, H.N., Smith, J.L., Levinsky, R.J., Ali, R.R., Kinnon, C., and Thrasher, A.J. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181-2187. (Pubitemid 40018447)
8. Gori, J.L., Podetz-Pedersen, K., Swanson, D., Karlen, A.D., Gunther, R., Somia, N.V., and McIvor, R.S. (2007). Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase. J Pharmacol Exp Ther 322, 989-997. (Pubitemid 47295791)
9. Grawunder, U., Wilm, M., Wu, X., Kulesza, P., Wilson, T.E., Mann, M., and Lieber, M.R. (1997). Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388, 492-495. (Pubitemid 27328929)
10. Grawunder, U., Zimmer, D., Kulesza, P., and Lieber, M.R. (1998). Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA doublestrand break repair in vivo. J Biol Chem 273, 24708-24714. (Pubitemid 28454971)
11. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Radford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Borkhardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., and Cavazzana-Calvo, M. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118, 3132-3142.
12. Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G.P., Berry, C.C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B.H., Leiva, L., Sorensen, R., Debre, M., Casanova, J.L., Blanche, S., Durandy, A., Bushman, F.D., Fischer, A., and Cavazzana-Calvo, M. (2010). Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363, 355-364.
13. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A.E., Kel, O.V., Ignatieva, E.V., Ananko, E.A., Podkolodnaya, O.A., Kolpakov, F.A., Podkolodny, N.L., and Kolchanov, N.A. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26, 362-367. (Pubitemid 28295292)
14. Howe, S.J., Mansour, M.R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M.H., Pike-Overzet, K., Chatters, S.J., de Ridder, D., Gilmour, K.C., Adams, S., Thornhill, S.I., Parsley, K.L., Staal, F.J., Gale, R.E., Linch, D.C., Bayford, J., Brown, L., Quaye, M., Kinnon, C., Ancliff, P., Webb, D.K., Schmidt, M., von Kalle, C., Gaspar, H.B., and Thrasher, A.J. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118, 3143-3150.
15. Lee, S.E., Mitchell, R.A., Cheng, A., and Hendrickson, E.A. (1997). Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Bio 17, 1425-1433. (Pubitemid 27097371)
16. Ma, Y., Pannicke, U., Schwarz, K., and Lieber, M.R. (2002). Hairpin opening and overhang processing by an Artemis/ DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108, 781-794. (Pubitemid 34327530)
17. McBlane, J.F., van Gent, D.C., Ramsden, D.A., Romeo, C., Cuomo, C.A., Gellert, M., and Oettinger, M.A. (1995). Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83, 387-395.
18. Mostoslavsky, G., Fabian, A.J., Rooney, S., Alt, F.W., and Mulligan, R.C. (2006). Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A 103, 16406-16411. (Pubitemid 44715209)
19. Multhaup, M.M., Karlen, A.D., Swanson, D.L., Wilber, A., Somia, N.V., Cowan, M.J., and McIvor, R.S. (2010). Cytotoxicity associated with Artemis over-expression after lentiviral vector mediated gene transfer. Hum Gene Ther 21, 865-875.
20. Oettinger, M.A., Schatz, D.G., Gorka, C., and Baltimore, D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517-1523.
21. Roth, D.B., Menetski, J.P., Nakajima, P.B., Bosma, M.J., and Gellert, M. (1992). V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in SCID mouse thymocytes. Cell 70, 983-991.
22. Takiguchi, Y., Kurimasa, A., Chen, F., Pardington, P.E., Kuriyama, T., Okinaka, R.T., Moyzis, R., and Chen, D.J. (1996). Genomic structure and chromosomal assignment of the mouse Ku70 gene. Genomics 35, 129-135. (Pubitemid 26236160)
23. Schibler, U., Hagenbuchle, O., Wellauer, P.K., and Pittet, A.C. (1983). Two promoters of different strengths control the transcription of the mouse alpha-amylase gene Amy-1a in the parotid gland and the liver. Cell 33, 501-508. (Pubitemid 13062498)
24. van Gent, D.C., McBlane, J.F., Ramsden, D.A., Sadofsky, M.J., Hesse, J.E., and Gellert, M. (1996). Initiation of V(D)J recom- binations in a cell-free system by RAG1 and RAG2 proteins. Curr Top Microbiol Immunol 217, 1-10.
25. West, R.B., Yaneva, M., and Lieber, M.R. (1998). Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini. Mol Cell Biol 18, 5908-5920.
26. Wilber, A., Linehan, J.L., Tian, X., Woll, P.S., Morris, J.K., Belur, L.R., McIvor, R.S., and Kaufman, D.S. (2007). Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 25, 2919-2927. (Pubitemid 350127877)
27. Yaneva, M., Kowalewski, T., and Lieber, M.R. (1997). Interaction of DNA-dependent protein kinase with DNA and with Ku: biochemical and atomic-force microscopy studies. EMBO J 16, 5098-5112. (Pubitemid 27348418)
28. Zhu, C., Bogue, M.A., Lim, D.S., Hasty, P., and Roth, D.B. (1996). Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389. (Pubitemid 26272078)
29. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15, 871-875.